301089SZSE

Tuo Xin Pharmaceutical Co., Ltd.

拓新药业

301089

Shenzhen Stock Exchange

61 announcements tracked· Last: September 30, 2026

Key Financials

Revenue¥211.3M

Net Profit-¥28.0M

ROE-1.92%

Debt Ratio10.66%

Monetary Funds¥74.7M

Receivables¥59.7M

Total Shares126.5M

Announcements

61 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.